Results 11 to 20 of about 46,164 (349)
JCIS Open, 2021 Hypothesis: Biophysical property and water evaporation retardation through a lipid nanofilm can be altered by model tear protein and topical ophthalmic formulation.
Meng C. Lin, Tatyana F. Svitova
doaj +1 more source
Central Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patient
Trends in Pediatrics, 2021 Cyclopentolate hydrochloride, belonging to a class of drugs known as anticholinergics, is an ophthalmic solution frequently used in ophthalmology clinics because of its cycloplegic and mydriatic effects in both refractions as well as fundus examinations.
Nazan Kaymaz +4 more
doaj +1 more source
Recalcitrant Pseudomonas Aeruginosa Keratitis with Hyphaema
Case Reports in Ophthalmology, 2021 Purpose: To report a case of recalcitrant pseudomonas keratitis with a rare presentation of hyphaema. Observation: A 45-year-old female was noted to have contact lens-related pseudomonas keratitis with hyphaema.
Amy Chan +3 more
doaj +1 more source
Frontiers in Medicine, 2022 BackgroundTo observe and compare the efficacy of 2% ganciclovir eye drops in the treatment of Posner-Schlossman Syndrome relapses with/without cytomegalovirus intraocular reactivation.MethodsA prospective cohort study enrolling 101 patients diagnosed ...
Qilian Sheng +11 more
doaj +1 more source
New ophthalmic drug delivery systems [PDF]
Farmacia Hospitalaria, 2020 For decades, topical ophthalmic drug administration through the use of eye drops has been the most widely used technique for the treatment of eye diseases.
Ana Castro-Balado +3 more
doaj +1 more source
A Review on Conventional and Novel Topical Ocular Drug Delivery System
Journal of Pharmacy, 2021 Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists due to the structural and barrier complexity of the eye.
Mohamad Faeznudin Rozi +1 more
doaj +1 more source
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [PDF]
, 2020 Introduction. Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antago- nist, where the primary use is for glaucoma.
Aggarwal, Dipika +10 more
core +2 more sources
Evaluation of the sterility condition of commonly used eye drops present in the Egyptian pharmacies. [PDF]
Journal of Bioscience and Applied Research, 2016 Fourty samples of commonly used eye drops were collected from The Egyptian Pharmacies and divided into 2 groups: group A (with antimicrobial activity) and group B (without antimicrobial activity), the two groups cultured on blood agar medium and ...
A.A. Abo Elnasr +4 more
doaj +1 more source
NIGHTMARES FROM TOPICAL TIMOLOL EYE DROPS: A CASE REPORT
Khyber Medical University Journal, 2020 Topical timolol eyedrops are frequently used as medical treatment of glaucoma. They decrease the production of aqueous humor by blocking the beta adrenergic receptors of ciliary body.
Yousaf Jamal Mahsood, Saima Farooq
doaj +1 more source
Stability of extemporaneously prepared ophthalmic solutions for mydriasis [PDF]
, 2018 Purpose Results of an evaluation of the physical and chemical stability of extemporaneously prepared adult and pediatric ophthalmic solutions containing combinations of phenylephrine, tropicamide, and cyclopentolate are reported.
Camp, Nicole A. +4 more
core +2 more sources